Small-molecule OPA1 inhibitors reverse mitochondrial adaptations to overcome therapy resistance in acute myeloid leukemia Targeting OPA1-mediated mitochondrial ultrastructural adaptations circumvents therapy resistance in acute leukemia.

Big news from the #Glytsoulab today!✍️Our research on drug resistance in leukemia is published in
@ScienceAdvances
Targeting OPA1 can help overcome therapy resistance in AML, including the most challenging cases. www.science.org/doi/10.1126/...

Hematologic Malignancies

Marta Romo is representing the #Glytsoulab at the FASEB Heme Malignancy conference this week. Stop by her poster tomorrow to check out her recent research findings 🧪 #HEMSRC events.faseb.org/event/7960e1...